Cargando…

The efficacy and stability of an information and communication technology-based centralized monitoring system of adherence to immunosuppressive medication in kidney transplant recipients: study protocol for a randomized controlled trial

BACKGROUND: Immunosuppression non-adherence in kidney transplant recipients (KTRs) not only increases the risk of medical intervention due to acute rejection and graft loss but burdens the socioeconomic system in the form of increased healthcare costs. An aggressive preemptive effort by healthcare p...

Descripción completa

Detalles Bibliográficos
Autores principales: Jung, Hee-Yeon, Seong, Sook Jin, Choi, Ji-Young, Cho, Jang-Hee, Park, Sun-Hee, Kim, Chan-Duck, Yoon, Young-Ran, Kim, Hyung-Kee, Huh, Seung, Yoon, Se-Hee, Lee, Jong Soo, Kim, Yong-Lim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5644178/
https://www.ncbi.nlm.nih.gov/pubmed/29037222
http://dx.doi.org/10.1186/s13063-017-2221-z
_version_ 1783271682934308864
author Jung, Hee-Yeon
Seong, Sook Jin
Choi, Ji-Young
Cho, Jang-Hee
Park, Sun-Hee
Kim, Chan-Duck
Yoon, Young-Ran
Kim, Hyung-Kee
Huh, Seung
Yoon, Se-Hee
Lee, Jong Soo
Kim, Yong-Lim
author_facet Jung, Hee-Yeon
Seong, Sook Jin
Choi, Ji-Young
Cho, Jang-Hee
Park, Sun-Hee
Kim, Chan-Duck
Yoon, Young-Ran
Kim, Hyung-Kee
Huh, Seung
Yoon, Se-Hee
Lee, Jong Soo
Kim, Yong-Lim
author_sort Jung, Hee-Yeon
collection PubMed
description BACKGROUND: Immunosuppression non-adherence in kidney transplant recipients (KTRs) not only increases the risk of medical intervention due to acute rejection and graft loss but burdens the socioeconomic system in the form of increased healthcare costs. An aggressive preemptive effort by healthcare professionals, geared to ensure adherence to immunosuppressants in KTRs, is significant and imperative. METHODS/DESIGN: This study was designed as a prospective, open-label, multicenter, randomized controlled study aimed at evaluating the efficacy and stability of an information and communication technology (ICT)-based centralized monitoring system in boosting medication adherence in KTRs. One hundred fourteen KTRs registered throughout the year 2017 to 2018 are randomized into either the ICT-based centralized home monitoring system or to ambulatory follow-up. The planned follow-up duration is 6 months. The ICT-based centralized home monitoring system described consists of a smart pill box equipped with personal identification system, a home monitoring system, an electronic Case Report Form (eCRF) system, and a comprehensive clinical trial management system (CTMS). It alerts both patients and medical staff with texts and pill box alarms if there is a dosage/dosing time error or a missed dose. Medication adherence and transplant outcomes for the follow-up period are compared between the two groups, while patient satisfaction as well as the stability and cost-effectiveness of the ICT-based monitoring system are to be evaluated. DISCUSSION: This on-going study is expected to determine if consistent use of the ICT-based centralized monitoring system described could maximize mediation adherence and subsequently enhance transplant outcomes in KTRs. Further, it would lay the foundation for successful implementation of this ICT-based monitoring system for effective management of medication adherence in KTRs. TRIALS REGISTRATION: ClinicalTrials.gov, Identifier: NCT03136588. Registered on 20 April 2017. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13063-017-2221-z) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5644178
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-56441782017-10-26 The efficacy and stability of an information and communication technology-based centralized monitoring system of adherence to immunosuppressive medication in kidney transplant recipients: study protocol for a randomized controlled trial Jung, Hee-Yeon Seong, Sook Jin Choi, Ji-Young Cho, Jang-Hee Park, Sun-Hee Kim, Chan-Duck Yoon, Young-Ran Kim, Hyung-Kee Huh, Seung Yoon, Se-Hee Lee, Jong Soo Kim, Yong-Lim Trials Study Protocol BACKGROUND: Immunosuppression non-adherence in kidney transplant recipients (KTRs) not only increases the risk of medical intervention due to acute rejection and graft loss but burdens the socioeconomic system in the form of increased healthcare costs. An aggressive preemptive effort by healthcare professionals, geared to ensure adherence to immunosuppressants in KTRs, is significant and imperative. METHODS/DESIGN: This study was designed as a prospective, open-label, multicenter, randomized controlled study aimed at evaluating the efficacy and stability of an information and communication technology (ICT)-based centralized monitoring system in boosting medication adherence in KTRs. One hundred fourteen KTRs registered throughout the year 2017 to 2018 are randomized into either the ICT-based centralized home monitoring system or to ambulatory follow-up. The planned follow-up duration is 6 months. The ICT-based centralized home monitoring system described consists of a smart pill box equipped with personal identification system, a home monitoring system, an electronic Case Report Form (eCRF) system, and a comprehensive clinical trial management system (CTMS). It alerts both patients and medical staff with texts and pill box alarms if there is a dosage/dosing time error or a missed dose. Medication adherence and transplant outcomes for the follow-up period are compared between the two groups, while patient satisfaction as well as the stability and cost-effectiveness of the ICT-based monitoring system are to be evaluated. DISCUSSION: This on-going study is expected to determine if consistent use of the ICT-based centralized monitoring system described could maximize mediation adherence and subsequently enhance transplant outcomes in KTRs. Further, it would lay the foundation for successful implementation of this ICT-based monitoring system for effective management of medication adherence in KTRs. TRIALS REGISTRATION: ClinicalTrials.gov, Identifier: NCT03136588. Registered on 20 April 2017. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13063-017-2221-z) contains supplementary material, which is available to authorized users. BioMed Central 2017-10-16 /pmc/articles/PMC5644178/ /pubmed/29037222 http://dx.doi.org/10.1186/s13063-017-2221-z Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Study Protocol
Jung, Hee-Yeon
Seong, Sook Jin
Choi, Ji-Young
Cho, Jang-Hee
Park, Sun-Hee
Kim, Chan-Duck
Yoon, Young-Ran
Kim, Hyung-Kee
Huh, Seung
Yoon, Se-Hee
Lee, Jong Soo
Kim, Yong-Lim
The efficacy and stability of an information and communication technology-based centralized monitoring system of adherence to immunosuppressive medication in kidney transplant recipients: study protocol for a randomized controlled trial
title The efficacy and stability of an information and communication technology-based centralized monitoring system of adherence to immunosuppressive medication in kidney transplant recipients: study protocol for a randomized controlled trial
title_full The efficacy and stability of an information and communication technology-based centralized monitoring system of adherence to immunosuppressive medication in kidney transplant recipients: study protocol for a randomized controlled trial
title_fullStr The efficacy and stability of an information and communication technology-based centralized monitoring system of adherence to immunosuppressive medication in kidney transplant recipients: study protocol for a randomized controlled trial
title_full_unstemmed The efficacy and stability of an information and communication technology-based centralized monitoring system of adherence to immunosuppressive medication in kidney transplant recipients: study protocol for a randomized controlled trial
title_short The efficacy and stability of an information and communication technology-based centralized monitoring system of adherence to immunosuppressive medication in kidney transplant recipients: study protocol for a randomized controlled trial
title_sort efficacy and stability of an information and communication technology-based centralized monitoring system of adherence to immunosuppressive medication in kidney transplant recipients: study protocol for a randomized controlled trial
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5644178/
https://www.ncbi.nlm.nih.gov/pubmed/29037222
http://dx.doi.org/10.1186/s13063-017-2221-z
work_keys_str_mv AT jungheeyeon theefficacyandstabilityofaninformationandcommunicationtechnologybasedcentralizedmonitoringsystemofadherencetoimmunosuppressivemedicationinkidneytransplantrecipientsstudyprotocolforarandomizedcontrolledtrial
AT seongsookjin theefficacyandstabilityofaninformationandcommunicationtechnologybasedcentralizedmonitoringsystemofadherencetoimmunosuppressivemedicationinkidneytransplantrecipientsstudyprotocolforarandomizedcontrolledtrial
AT choijiyoung theefficacyandstabilityofaninformationandcommunicationtechnologybasedcentralizedmonitoringsystemofadherencetoimmunosuppressivemedicationinkidneytransplantrecipientsstudyprotocolforarandomizedcontrolledtrial
AT chojanghee theefficacyandstabilityofaninformationandcommunicationtechnologybasedcentralizedmonitoringsystemofadherencetoimmunosuppressivemedicationinkidneytransplantrecipientsstudyprotocolforarandomizedcontrolledtrial
AT parksunhee theefficacyandstabilityofaninformationandcommunicationtechnologybasedcentralizedmonitoringsystemofadherencetoimmunosuppressivemedicationinkidneytransplantrecipientsstudyprotocolforarandomizedcontrolledtrial
AT kimchanduck theefficacyandstabilityofaninformationandcommunicationtechnologybasedcentralizedmonitoringsystemofadherencetoimmunosuppressivemedicationinkidneytransplantrecipientsstudyprotocolforarandomizedcontrolledtrial
AT yoonyoungran theefficacyandstabilityofaninformationandcommunicationtechnologybasedcentralizedmonitoringsystemofadherencetoimmunosuppressivemedicationinkidneytransplantrecipientsstudyprotocolforarandomizedcontrolledtrial
AT kimhyungkee theefficacyandstabilityofaninformationandcommunicationtechnologybasedcentralizedmonitoringsystemofadherencetoimmunosuppressivemedicationinkidneytransplantrecipientsstudyprotocolforarandomizedcontrolledtrial
AT huhseung theefficacyandstabilityofaninformationandcommunicationtechnologybasedcentralizedmonitoringsystemofadherencetoimmunosuppressivemedicationinkidneytransplantrecipientsstudyprotocolforarandomizedcontrolledtrial
AT yoonsehee theefficacyandstabilityofaninformationandcommunicationtechnologybasedcentralizedmonitoringsystemofadherencetoimmunosuppressivemedicationinkidneytransplantrecipientsstudyprotocolforarandomizedcontrolledtrial
AT leejongsoo theefficacyandstabilityofaninformationandcommunicationtechnologybasedcentralizedmonitoringsystemofadherencetoimmunosuppressivemedicationinkidneytransplantrecipientsstudyprotocolforarandomizedcontrolledtrial
AT kimyonglim theefficacyandstabilityofaninformationandcommunicationtechnologybasedcentralizedmonitoringsystemofadherencetoimmunosuppressivemedicationinkidneytransplantrecipientsstudyprotocolforarandomizedcontrolledtrial
AT jungheeyeon efficacyandstabilityofaninformationandcommunicationtechnologybasedcentralizedmonitoringsystemofadherencetoimmunosuppressivemedicationinkidneytransplantrecipientsstudyprotocolforarandomizedcontrolledtrial
AT seongsookjin efficacyandstabilityofaninformationandcommunicationtechnologybasedcentralizedmonitoringsystemofadherencetoimmunosuppressivemedicationinkidneytransplantrecipientsstudyprotocolforarandomizedcontrolledtrial
AT choijiyoung efficacyandstabilityofaninformationandcommunicationtechnologybasedcentralizedmonitoringsystemofadherencetoimmunosuppressivemedicationinkidneytransplantrecipientsstudyprotocolforarandomizedcontrolledtrial
AT chojanghee efficacyandstabilityofaninformationandcommunicationtechnologybasedcentralizedmonitoringsystemofadherencetoimmunosuppressivemedicationinkidneytransplantrecipientsstudyprotocolforarandomizedcontrolledtrial
AT parksunhee efficacyandstabilityofaninformationandcommunicationtechnologybasedcentralizedmonitoringsystemofadherencetoimmunosuppressivemedicationinkidneytransplantrecipientsstudyprotocolforarandomizedcontrolledtrial
AT kimchanduck efficacyandstabilityofaninformationandcommunicationtechnologybasedcentralizedmonitoringsystemofadherencetoimmunosuppressivemedicationinkidneytransplantrecipientsstudyprotocolforarandomizedcontrolledtrial
AT yoonyoungran efficacyandstabilityofaninformationandcommunicationtechnologybasedcentralizedmonitoringsystemofadherencetoimmunosuppressivemedicationinkidneytransplantrecipientsstudyprotocolforarandomizedcontrolledtrial
AT kimhyungkee efficacyandstabilityofaninformationandcommunicationtechnologybasedcentralizedmonitoringsystemofadherencetoimmunosuppressivemedicationinkidneytransplantrecipientsstudyprotocolforarandomizedcontrolledtrial
AT huhseung efficacyandstabilityofaninformationandcommunicationtechnologybasedcentralizedmonitoringsystemofadherencetoimmunosuppressivemedicationinkidneytransplantrecipientsstudyprotocolforarandomizedcontrolledtrial
AT yoonsehee efficacyandstabilityofaninformationandcommunicationtechnologybasedcentralizedmonitoringsystemofadherencetoimmunosuppressivemedicationinkidneytransplantrecipientsstudyprotocolforarandomizedcontrolledtrial
AT leejongsoo efficacyandstabilityofaninformationandcommunicationtechnologybasedcentralizedmonitoringsystemofadherencetoimmunosuppressivemedicationinkidneytransplantrecipientsstudyprotocolforarandomizedcontrolledtrial
AT kimyonglim efficacyandstabilityofaninformationandcommunicationtechnologybasedcentralizedmonitoringsystemofadherencetoimmunosuppressivemedicationinkidneytransplantrecipientsstudyprotocolforarandomizedcontrolledtrial